The DOJ’s order to reclassify marijuana could be a boon for US cannabis companies. But the devil is in the details.

A Q&A with John Love, vice president of Amazon Pharmacy.

Hims providers can now send prescriptions to Eli Lilly’s direct-to-consumer pharmacy.

Lyft describes its international expansion strategy as “expanding ‘out’ in more locations and ‘up’ into more high-value segments.”

Psychedelic biotech stocks were already on a tear before Trump’s executive order sent them shooting higher.

The company, which is the first of its peers to report earnings this quarter, was up more than 6% in premarket trading.

The cost for its power site is mounting while it still doesn’t have any customers secured, according its annual report released on March 30.

Google has been increasingly positioning itself as a competitor to chip giants like Nvidia and AMD.

Novo’s pill had a stronger first week than Lilly’s, with its Wegovy pill hitting 3,071 US prescriptions in the first four days after its launch…

The stock is still down more than 20% from the start of the year through yesterday's close, taking a massive hit after its botched rollout…